{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:43:29Z","timestamp":1774449809132,"version":"3.50.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2010,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1111\/j.1432-2277.2010.01070.x","type":"journal-article","created":{"date-parts":[[2010,3,5]],"date-time":"2010-03-05T08:49:46Z","timestamp":1267778986000},"source":"Crossref","is-referenced-by-count":6,"title":["Autosomal dominant polycystic kidney disease: risk factor for nonmelanoma skin cancer following kidney transplantation"],"prefix":"10.3389","author":[{"given":"Anne","family":"Bretagnol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Michel","family":"Halimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Roland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Barbet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Machet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azmi","family":"Al Najjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Fr\u00e9d\u00e9ric","family":"Marli\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Badin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert","family":"Nivet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvon","family":"Lebranchu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"B\u00fcchler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","reference":[{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00007890-199603150-00008","article-title":"The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study","volume":"61","author":"Bouwes Bavinck","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2133.2007.08363.x","article-title":"Update on the pathogenesis of post-transplant skin cancer in renal transplant recipients","volume":"158","author":"Ho","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB3","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation","volume":"348","author":"Euvrard","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB4","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.tp.0000248759.37146.3d","article-title":"Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation","volume":"83","author":"Hamer","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jaad.2005.07.061","article-title":"Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease","volume":"53","author":"Otley","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1600-6143.2004.00450.x","article-title":"Cancer after kidney transplantation in the United States","volume":"4","author":"Kasiske","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB8","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archderm.1988.01670060015008","article-title":"The validity and practicality of sun-reactive skin types I through VI","volume":"124","author":"Fitzpatrick","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archderm.139.3.301","article-title":"Defining the clinical course of metastatic skin cancer in organ transplant recipients. A multicenter collaborative study","volume":"139","author":"Martinez","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(97)08496-1","article-title":"Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens","volume":"351","author":"Dantal","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/TP.0b013e318180482d","article-title":"Non-melanoma skin cancer incidence and risk factors after kidney transplantation: a Canadian experience","volume":"86","author":"Comeau","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/ajkd.2000.8290","article-title":"Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients","volume":"36","author":"Ramsay","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB13","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/sj.ki.5002154","article-title":"The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich","volume":"71","author":"Wimmer","year":"2007","journal-title":"Kidney Int"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.tp.0000269707.06060.dc","article-title":"Seven-year prospective study of nonmelanoma skin cancer incidence in U.K. renal transplant recipients","volume":"84","author":"Ramsay","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-0781.2007.00282.x","article-title":"Genetic factors associated with skin cancer in renal transplant patients","volume":"23","author":"Laing","year":"2007","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cellbi.2007.12.014","article-title":"Polycystin-1 induced apoptosis and cell cycle arrest in G0.G1 phase in cancer cells","volume":"32","author":"Zheng","year":"2008","journal-title":"Cell Biol Int"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB17","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1172\/JCI119090","article-title":"Identification and localization of polycystin, the PKD1 gene product","volume":"98","author":"Geng","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB18","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1523-1755.2005.67132.x","article-title":"Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation","volume":"67","author":"De Mattos","year":"2005","journal-title":"Kidney Int"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(08)61039-9","article-title":"Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial","volume":"372","author":"Motzer","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB20","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1038\/jid.2008.121","article-title":"Sirolimus reduces the incidence and progression of UVB-induced skin cancer in SKH mice even with co-administration of cyclosporine A","volume":"128","author":"Wulff","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1681\/ASN.2005090993","article-title":"Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation","volume":"17","author":"Campistol","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB22","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB23","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/gfi181","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)","volume":"21","author":"Wahl","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1432-2277.2010.01070.x-BIB24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2369-8-13","article-title":"Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study","volume":"8","author":"Serra","year":"2007","journal-title":"BMC Nephrol"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1432-2277.2010.01070.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1432-2277.2010.01070.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T18:34:17Z","timestamp":1641062057000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1432-2277.2010.01070.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":24,"URL":"https:\/\/doi.org\/10.1111\/j.1432-2277.2010.01070.x","relation":{},"ISSN":["0934-0874","1432-2277"],"issn-type":[{"value":"0934-0874","type":"print"},{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}